{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:19:48Z","timestamp":1780316388900,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"DOI":"10.7759\/cureus.89871","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T10:52:14Z","timestamp":1754995934000},"source":"Crossref","is-referenced-by-count":1,"title":["Decoding Silent Signals: A Systematic Review of ECG and the Quest for an Early Diagnosis of Cirrhotic Cardiomyopathy"],"prefix":"10.7759","author":[{"given":"Sanathanan","family":"Neelakantan Ramaswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samyuktha","family":"Harikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashasvi","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalvin","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manvitha","family":"Bendagiri Matam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20187809","article-title":"Cirrhotic cardiomyopathy: the liver affects the heart","volume":"52","author":"Carvalho MV","year":"2019","unstructured":"Carvalho MV, Kroll PC, Kroll RT, Carvalho VN. Cirrhotic cardiomyopathy: the liver affects the heart. Braz J Med Biol Res. 2019, 52:e7809. 10.1590\/1414-431X20187809","journal-title":"Braz J Med Biol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27969","article-title":"Cirrhotic cardiomyopathy: the interplay between liver and heart","volume":"14","author":"Kalluru R","year":"2022","unstructured":"Kalluru R, Gadde S, Chikatimalla R, Dasaradhan T, Koneti J, Cherukuri SP. Cirrhotic cardiomyopathy: the interplay between liver and heart. Cureus. 2022, 14:e27969. 10.7759\/cureus.27969","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56020068","article-title":"Electrocardiographic changes in liver cirrhosis\u2014clues for cirrhotic cardiomyopathy","volume":"56","author":"Toma L","year":"2020","unstructured":"Toma L, Stanciu AM, Zgura A, Bacalbasa N, Diaconu C, Iliescu L. Electrocardiographic changes in liver cirrhosis\u2014clues for cirrhotic cardiomyopathy. Medicina (Kaunas). 2020, 56:68. 10.3390\/medicina56020068","journal-title":"Medicina (Kaunas)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-025-10500-7","article-title":"Cirrhotic cardiomyopathy: comprehensive insights into pathophysiology, diagnosis, and management","volume":"30","author":"Ndakotsu A","year":"2025","unstructured":"Ndakotsu A, Nduka TC, Agrawal S, Asuka E. Cirrhotic cardiomyopathy: comprehensive insights into pathophysiology, diagnosis, and management. Heart Fail Rev. 2025, 30:739-48. 10.1007\/s10741-025-10500-7","journal-title":"Heart Fail Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/RRCC.S371615","article-title":"QT interval prolongation in cirrhotic cardiomyopathy","volume":"13","author":"Tadelle A","year":"2022","unstructured":"Tadelle A. QT interval prolongation in cirrhotic cardiomyopathy. Res Rep Clin Cardiol. 2022, 13:55-61. 10.2147\/RRCC.S371615","journal-title":"Res Rep Clin Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-023-10358-7","article-title":"Electrocardiographic abnormalities in patients with cardiomyopathies","volume":"29","author":"Aimo A","year":"2024","unstructured":"Aimo A, Milandri A, Barison A, et al.. Electrocardiographic abnormalities in patients with cardiomyopathies. Heart Fail Rev. 2024, 29:151-64. 10.1007\/s10741-023-10358-7","journal-title":"Heart Fail Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16500","article-title":"Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: a change in the current paradigm","volume":"21","author":"Koshy AN","year":"2021","unstructured":"Koshy AN, Gow PJ, Testro A, et al.. Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: a change in the current paradigm. Am J Transplant. 2021, 21:2240-5. 10.1111\/ajt.16500","journal-title":"Am J Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122132","article-title":"Cardiac imaging in liver transplantation candidates: current knowledge and future perspectives","volume":"8","author":"Dimitroglou Y","year":"2019","unstructured":"Dimitroglou Y, Aggeli C, Alexopoulou A, Mavrogeni S, Tousoulis D. Cardiac imaging in liver transplantation candidates: current knowledge and future perspectives. J Clin Med. 2019, 8:2132. 10.3390\/jcm8122132","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.08.016","article-title":"Diagnosis and management of cirrhotic cardiomyopathy","volume":"12","author":"Kaur H","year":"2022","unstructured":"Kaur H, Premkumar M. Diagnosis and management of cirrhotic cardiomyopathy. J Clin Exp Hepatol. 2022, 12:186-99. 10.1016\/j.jceh.2021.08.016","journal-title":"J Clin Exp Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3329\/cardio.v12i2.47987","article-title":"Electrocardiographic and echocardiographic profile of dilated cardiomyopathy patients","volume":"12","author":"Barman RN","year":"2020","unstructured":"Barman RN, Ghafur S, Sarkar H, Zahid MA, Mahmud MA, Rahman MM, Islam MH. Electrocardiographic and echocardiographic profile of dilated cardiomyopathy patients. Cardiovasc J. 2020, 12:109-12. 10.3329\/cardio.v12i2.47987","journal-title":"Cardiovasc J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8208609","article-title":"Biomarkers of cardiovascular disease","volume":"2017","author":"Huang Y","year":"2017","unstructured":"Huang Y, Gulshan K, Nguyen T, Wu Y. Biomarkers of cardiovascular disease. Dis Markers. 2017, 2017:8208609. 10.1155\/2017\/8208609","journal-title":"Dis Markers"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref13","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2021). Accessed. Aug 10, 2025: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge C","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019, 4:5. 10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019703","article-title":"Tools for assessing risk of reporting biases in studies and syntheses of studies: a systematic review","volume":"8","author":"Page MJ","year":"2018","unstructured":"Page MJ, McKenzie JE, Higgins JP. Tools for assessing risk of reporting biases in studies and syntheses of studies: a systematic review. BMJ Open. 2018, 8:e019703. 10.1136\/bmjopen-2017-019703","journal-title":"BMJ Open"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.29173\/jchla29801","article-title":"JBI Critical appraisal checklist for systematic reviews and research syntheses","volume":"45","author":"Hilton M","year":"2024","unstructured":"Hilton M. JBI Critical appraisal checklist for systematic reviews and research syntheses. J Can Health Libr Assoc. 2024, 45:180-3. 10.29173\/jchla29801","journal-title":"J Can Health Libr Assoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X15666190509084519","article-title":"Cirrhotic cardiomyopathy: the interplay between liver and cardiac muscle. How does the cardiovascular system react when the liver is diseased?","volume":"17","author":"Dourakis SP","year":"2021","unstructured":"Dourakis SP, Geladari E, Geladari C, Vallianou N. Cirrhotic cardiomyopathy: the interplay between liver and cardiac muscle. How does the cardiovascular system react when the liver is diseased?. Curr Cardiol Rev. 2021, 17:78-84. 10.2174\/1573403X15666190509084519","journal-title":"Curr Cardiol Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v15.i9.1060","article-title":"Corrected QT interval in cirrhosis: a systematic review and meta-analysis","volume":"15","author":"Papadopoulos VP","year":"2023","unstructured":"Papadopoulos VP, Mimidis K. Corrected QT interval in cirrhosis: a systematic review and meta-analysis. World J Hepatol. 2023, 15:1060-83. 10.4254\/wjh.v15.i9.1060","journal-title":"World J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1586\/egh.11.86","article-title":"QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?","volume":"6","author":"Bernardi M","year":"2012","unstructured":"Bernardi M, Maggioli C, Dibra V, Zaccherini G. QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?. Expert Rev Gastroenterol Hepatol. 2012, 6:57-66. 10.1586\/egh.11.86","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref20","article-title":"Assessment of cirrhotic cardiomyopathy in liver cirrhosis patients using ECG parameters and echocardiographic findings: a cross-sectional study","volume":"14","author":"Gollamudi KR","year":"2024","unstructured":"Gollamudi KR, Yarram RR, Bethapudi AK, Akula HR. Assessment of cirrhotic cardiomyopathy in liver cirrhosis patients using ECG parameters and echocardiographic findings: a cross-sectional study. Eur J Cardiovasc Med. 2024, 14:390-4.","journal-title":"Eur J Cardiovasc Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-020-00622-2","article-title":"Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study","volume":"22","author":"Kim HM","year":"2020","unstructured":"Kim HM, Kim HK, Lee JH, et al.. Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study. J Cardiovasc Magn Reson. 2020, 22:25. 10.1186\/s12968-020-00622-2","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14977","article-title":"Association of liver fibrosis-4 index with adverse outcomes in hypertrophic cardiomyopathy patients","volume":"11","author":"Abdu FA","year":"2024","unstructured":"Abdu FA, Mareai RM, Xiang L, et al.. Association of liver fibrosis-4 index with adverse outcomes in hypertrophic cardiomyopathy patients. ESC Heart Fail. 2024, 11:3934-45. 10.1002\/ehf2.14977","journal-title":"ESC Heart Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3325\/cmj.2023.64.362","article-title":"Markers of cardiac injury in patients with liver cirrhosis","volume":"64","author":"\u0160imi\u0107 S","year":"2023","unstructured":"\u0160imi\u0107 S, Svagu\u0161a T, Grgurevi\u0107 I, Mustapi\u0107 S, \u017darak M, Prka\u010din I. Markers of cardiac injury in patients with liver cirrhosis. Croat Med J. 2023, 64:362-73. 10.3325\/cmj.2023.64.362","journal-title":"Croat Med J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2021.100821","article-title":"Diagnosis and prevalence of cirrhotic cardiomyopathy: a systematic review and meta-analysis","volume":"46","author":"Shahvaran SA","year":"2021","unstructured":"Shahvaran SA, Menyh\u00e1rt O, Csedrik L, Patai \u00c1V. Diagnosis and prevalence of cirrhotic cardiomyopathy: a systematic review and meta-analysis. Curr Probl Cardiol. 2021, 46:100821. 10.1016\/j.cpcardiol.2021.100821","journal-title":"Curr Probl Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63388","article-title":"Evaluating diastolic dysfunction as an indicator of cirrhotic cardiomyopathy in decompensated chronic liver disease","volume":"16","author":"Kumar P","year":"2024","unstructured":"Kumar P, Shikoh A, Rani N. Evaluating diastolic dysfunction as an indicator of cirrhotic cardiomyopathy in decompensated chronic liver disease. Cureus. 2024, 16:e63388. 10.7759\/cureus.63388","journal-title":"Cureus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5009\/gnl210537","article-title":"Prolonged QT interval in cirrhosis: twisting time?","volume":"16","author":"Lee W","year":"2022","unstructured":"Lee W, Vandenberk B, Raj SR, Lee SS. Prolonged QT interval in cirrhosis: twisting time?. Gut Liver. 2022, 16:849-60. 10.5009\/gnl210537","journal-title":"Gut Liver"},{"key":"ref27","article-title":"Cardiovascular dysfunction in patients with liver cirrhosis","volume":"28","author":"Fede G","year":"2015","unstructured":"Fede G, Privitera G, Tomaselli T, Spadaro L, Purrello F. Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol. 2015, 28:31-40.","journal-title":"Ann Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_341_20","article-title":"QTc prolongation in patients of cirrhosis and its relation with disease severity: an observational study from a rural teaching hospital","volume":"9","author":"Bhardwaj A","year":"2020","unstructured":"Bhardwaj A, Joshi S, Sharma R, Bhardwaj S, Agrawal R, Gupta N. QTc prolongation in patients of cirrhosis and its relation with disease severity: an observational study from a rural teaching hospital. J Family Med Prim Care. 2020, 9:3020-4. 10.4103\/jfmpc.jfmpc_341_20","journal-title":"J Family Med Prim Care"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10018-1291","article-title":"Association of cirrhosis and cardiomyopathy","volume":"9","author":"Sezgin B","year":"2019","unstructured":"Sezgin B, Cindoglu C, Uyanikoglu A, Yenice N. Association of cirrhosis and cardiomyopathy. Euroasian J Hepatogastroenterol. 2019, 9:23-6. 10.5005\/jp-journals-10018-1291","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2016.57962","article-title":"The heart matters when the liver shatters! Cirrhotic cardiomyopathy: frequency, comparison, and correlation with severity of disease","volume":"11","author":"Naqvi IH","year":"2016","unstructured":"Naqvi IH, Mahmood K, Naeem M, Vashwani AS, Ziaullah S. The heart matters when the liver shatters! Cirrhotic cardiomyopathy: frequency, comparison, and correlation with severity of disease. Prz Gastroenterol. 2016, 11:247-56. 10.5114\/pg.2016.57962","journal-title":"Prz Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.47162\/RJME.65.4.16","article-title":"Electrophysiological parameters in patients with hepatic cirrhosis","volume":"65","author":"Lupu D","year":"2024","unstructured":"Lupu D, St\u0103nescu C, Nedelcu DL, Stoica GA, Botezat MM, Lupu A\u015e. Electrophysiological parameters in patients with hepatic cirrhosis. Rom J Morphol Embryol. 2024, 65:687-92. 10.47162\/RJME.65.4.16","journal-title":"Rom J Morphol Embryol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6934418","article-title":"Comparison of electrocardiogram and QT interval between viral hepatitis cirrhosis and alcoholic cirrhosis","volume":"2022","author":"Lu LH","year":"2022","unstructured":"Lu LH, Lv XY, Wu QM, et al.. Comparison of electrocardiogram and QT interval between viral hepatitis cirrhosis and alcoholic cirrhosis. Cardiol Res Pract. 2022, 2022:6934418. 10.1155\/2022\/6934418","journal-title":"Cardiol Res Pract"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.12865\/CHSJ.44.03.11","article-title":"Q-T interval prolongation in patients with liver cirrhosis","volume":"44","author":"\u021aieranu E","year":"2018","unstructured":"\u021aieranu E, Donoiu I, Istr\u0103toaie O, G\u0103man AE, \u021aieranu LM, Gheonea DI, Ciurea T. Q-T interval prolongation in patients with liver cirrhosis\r\n. Curr Health Sci J. 2018, 44:274-9. 10.12865\/CHSJ.44.03.11","journal-title":"Curr Health Sci J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v9.i1.28","article-title":"Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity","volume":"9","author":"Tsiompanidis E","year":"2018","unstructured":"Tsiompanidis E, Siakavellas SI, Tentolouris A, et al.. Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity. World J Gastrointest Pathophysiol. 2018, 9:28-36. 10.4291\/wjgp.v9.i1.28","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2021.01.012","article-title":"Current concepts of cirrhotic cardiomyopathy","volume":"25","author":"Izzy MJ","year":"2021","unstructured":"Izzy MJ, VanWagner LB. Current concepts of cirrhotic cardiomyopathy. Clin Liver Dis. 2021, 25:471-81. 10.1016\/j.cld.2021.01.012","journal-title":"Clin Liver Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/life14020179","article-title":"The contemporary role of speckle tracking echocardiography in cirrhotic cardiomyopathy","volume":"14","author":"Dimitroglou Y","year":"2024","unstructured":"Dimitroglou Y, Aggeli C, Alexopoulou A, et al.. The contemporary role of speckle tracking echocardiography in cirrhotic cardiomyopathy. Life (Basel). 2024, 14:179. 10.3390\/life14020179","journal-title":"Life (Basel)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v12.i8.373","article-title":"Sympathetic nervous system activation and heart failure: current state of evidence and the pathophysiology in the light of novel biomarkers","volume":"12","author":"Borovac JA","year":"2020","unstructured":"Borovac JA, D'Amario D, Bozic J, Glavas D. Sympathetic nervous system activation and heart failure: current state of evidence and the pathophysiology in the light of novel biomarkers. World J Cardiol. 2020, 12:373-408. 10.4330\/wjc.v12.i8.373","journal-title":"World J Cardiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa124","article-title":"Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy","volume":"116","author":"Coppini R","year":"2020","unstructured":"Coppini R, Santini L, Olivotto I, Ackerman MJ, Cerbai E. Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy. Cardiovasc Res. 2020, 116:1585-99. 10.1093\/cvr\/cvaa124","journal-title":"Cardiovasc Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00072","article-title":"Calcium handling defects and cardiac arrhythmia syndromes","volume":"11","author":"Kistam\u00e1s K","year":"2020","unstructured":"Kistam\u00e1s K, Veress R, Horv\u00e1th B, B\u00e1ny\u00e1sz T, N\u00e1n\u00e1si PP, Eisner DA. Calcium handling defects and cardiac arrhythmia syndromes. Front Pharmacol. 2020, 11:72. 10.3389\/fphar.2020.00072","journal-title":"Front Pharmacol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/clc.24089","article-title":"Electrocardiographic characteristics of cirrhotic patients and their association with Child-Pugh score","volume":"46","author":"Jahangiri S","year":"2023","unstructured":"Jahangiri S, Abdiardekani A, Jamshidi S, et al.. Electrocardiographic characteristics of cirrhotic patients and their association with Child-Pugh score. Clin Cardiol. 2023, 46:967-72. 10.1002\/clc.24089","journal-title":"Clin Cardiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1178163","article-title":"The pivotal role of ECG in cardiomyopathies","volume":"10","author":"Silvetti E","year":"2023","unstructured":"Silvetti E, Lanza O, Romeo F, et al.. The pivotal role of ECG in cardiomyopathies. Front Cardiovasc Med. 2023, 10:1178163. 10.3389\/fcvm.2023.1178163","journal-title":"Front Cardiovasc Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2217\/fca-2021-0010","article-title":"Harnessing artificial intelligence in cardiac rehabilitation, a systematic review","volume":"18","author":"Sotirakos S","year":"2022","unstructured":"Sotirakos S, Fouda B, Mohamed Razif NA, et al.. Harnessing artificial intelligence in cardiac rehabilitation, a systematic review. Future Cardiol. 2022, 18:154-64. 10.2217\/fca-2021-0010","journal-title":"Future Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/391494-decoding-silent-signals-a-systematic-review-of-ecg-and-the-quest-for-an-early-diagnosis-of-cirrhotic-cardiomyopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T10:52:15Z","timestamp":1754995935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/391494-decoding-silent-signals-a-systematic-review-of-ecg-and-the-quest-for-an-early-diagnosis-of-cirrhotic-cardiomyopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.89871","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}